673Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation

MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation Pamela Moise, PharmD; Darren Culshaw, PharmD; Annie Wong-Beringer, PharmD; Joyce Bensman, PharmD; Kenneth Lamp, PharmD; Winter J. Smith, PharmD; Karri Bauer, PharmD; Debra Goff, PharmD; Robert Adamson, PharmD; Kimberly Leuthner, PharmD; Michael Virata, MD; James A. Mckinnell, MD; Saira B. Chaudhry, PharmD, MPH; Romic Eskandarian, PharmD; Thomas Lodise, PharmD; Katherine Reyes, MD; Marcus Zervos, MD; Cubist Pharmaceuticals, Lexington, MA; Huntington Hospital, Los Angeles, CA; University of Southern California, Los Angeles, CA; University of Oklahoma Health Sciences Center, Oklahoma City, OK; Ohio State University Medical Center, Columbus, OH; St. Barnabas Health Care System, Livingston, NJ; University Medical Center of Southern Nevada, Las Vegas, NV; Hospital of Saint Raphael, New Haven, CT; Torrance Memorial Medical Center, Torrance, CA; Infectious Disease Clinical Outcomes Research Unit (ID-CORE) at Los Angeles Biomedical Research Institute, Torrance, CA; Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Piscataway, NJ; Glendale Adventist Medical Center, Glendale, CA; Albany College of Pharmacy, Albany, NY; Henry Ford Hospital, Detroit, MI